CompletedACTRN12619000726156
Official study titleAn experimental study of the influence of choice (versus no choice) of placebo treatment on reported side effects (nocebo effects) in healthy participants
This study has finished and is no longer accepting participants.
In AustraliaAnxietyInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Dr Kate Faasse
CompletedNCT01502436
About this title
An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
Read the official source — NCT01502436Official study titleAn Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
This study has finished and is no longer accepting participants.
In DenverSuicidality, PTSDObservational studyAges 18–89
- Countries
- United States
- Sponsor
- VA Eastern Colorado Health Care System
CompletedNCT05737550
Official study titleA Second Explorative Pilot Study Evaluating Usability and Functionality of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With Confirmed Substance Use Disorder (SUD)
This study has finished and is no longer accepting participants.
In UppsalaAddictionDevice studyAges 18+
- Countries
- Sweden
- Sponsor
- Kontigo Care AB
TerminatedNCT05741502
Official study titleAn Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Versus Non-Clozapine Antipsychotics in Individuals With Treatment-resistant Schizophrenia
This study ended early.
In ColumbusSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Ohio State University
CompletedNCT00996242
About this title
An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
Read the official source — NCT00996242Official study titleAn Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In GothenburgSchizophreniaMedication studyAges 23–56
- Countries
- Sweden
- Sponsor
- Göteborg University
CompletedNCT00257023
About this title
An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia
Read the official source — NCT00257023What is this study about?This study evaluated the safety and effectiveness of paliperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 20–64
- Countries
- Sponsor
- Janssen Pharmaceutical K.K.
CompletedNCT00683462
About this title
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Read the official source — NCT00683462What is this study about?Researchers compared AZD3480 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
In BurlingtonADHDMedication studyAges 18–65
- Countries
- United States
- Sponsor
- AstraZeneca
TerminatedEUCTR 2012-002954-21
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumDepressionHistorical research record
- Countries
- Belgium, Netherlands, Spain
- Sponsor
- Janssen-Cilag International N.V.
CompletedNCT06486948
Official study titleA Multicenter, Exploratory, Randomized, Double-Arm, 8-week Study to Evaluate the Feasibility and Acceptability of an Abbreviated Treatment with CT-156 in People with Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkSchizophreniaDevice studyAges 18+
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.